GENES-BASEL 润色咨询

Genes

出版年份:暂无数据 年文章数:6959 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:5.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2020-08-11 145d9400m83暂无昵称

    还收国人的文章吗

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2021-08-06 努力yy

    审稿速度:1.0
    偏重的研究方向: 基因组学
    经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2021-08-16 莱纳德

    偏重的研究方向:生物信息;肿瘤
    经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2021-11-29 1196658850

    审稿速度:1.0
    经验分享:一个半月了还是under review

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2021-12-21 ms6000002125994814

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:第一篇SCI,贡献自己的经验。
    11.14投稿;
    12.12左右意见小修,三天修回;
    修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。
    编辑很认真负责,沟通非常流畅。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2018-06-20 windowsie

    审稿速度:2.0
    经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2022-04-07 ms8000001846163417

    偏重的研究方向:肿瘤;生物信息
    经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2022-10-25 5321

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:基因
    经验分享:医院

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2022-02-18 liuli1991dr

    偏重的研究方向:生信;基因
    经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=807482, encodeId=82fe80e482ea, content=还收国人的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Tue Aug 11 15:32:35 CST 2020, time=2020-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005566, encodeId=760810055660e, content=审稿速度:1.0<br>偏重的研究方向: 基因组学 <br>经验分享:投稿一天被拒,创新和总体意义不够。投IJMS也是这个原因,3天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92655553399, createdName=努力yy, createdTime=Fri Aug 06 10:22:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008241, encodeId=0b30100824168, content=偏重的研究方向:生物信息;肿瘤<br>经验分享:投IJMS三天被拒,过来投这个也是三天被拒,也没有理由🥲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9365264418, createdName=莱纳德, createdTime=Mon Aug 16 09:00:48 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075057, encodeId=b0b610e505793, content=审稿速度:1.0<br>经验分享:一个半月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67e23064091, createdName=1196658850, createdTime=Mon Nov 29 13:20:05 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082602, encodeId=8285108260286, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:第一篇SCI,贡献自己的经验。<br>11.14投稿;<br>12.12左右意见小修,三天修回;<br>修回后大概五天接收,然后就开始交版面费,开始校稿。2000法郎。<br>编辑很认真负责,沟通非常流畅。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37245707316, createdName=ms6000002125994814, createdTime=Tue Dec 21 16:04:44 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558112, encodeId=187855811202, content=审稿速度:2.0<br>经验分享:投的GENES的Special Issue,Received: 3 May 2018 / Revised: 28 May 2018 / Accepted: 12 June 2018 / Published: 18 June 2018, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850c1668377, createdName=windowsie, createdTime=Wed Jun 20 00:33:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209237, encodeId=0957120923e2b, content=偏重的研究方向:肿瘤;生物信息<br>经验分享:审稿就要收钱吗,不管接不接收吗? 我前两天投的,今天来邮件说要交CHF 2160。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e59e5610533, createdName=ms8000001846163417, createdTime=Thu Apr 07 14:59:52 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096159, encodeId=bede209615920, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:基因<br>经验分享:医院, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56b05499114, createdName=5321, createdTime=Tue Oct 25 23:14:01 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194781, encodeId=425b1194e8138, content=偏重的研究方向:生信;基因<br>经验分享:传言MDPI不收中国医院的文章不知是否可靠?投了生信+验证的一篇文章,秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf2600009, createdName=liuli1991dr, createdTime=Fri Feb 18 12:09:03 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218790, encodeId=c0fe1218e9021, content=投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49235689529, createdName=ms9000000734077640, createdTime=Wed May 11 16:59:28 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2022-05-11 ms9000000734077640

    投稿一周,目前依旧是pending review无动静,问一下有经历过这个阶段的伙伴们都多长时间?

    5

    展开5条回复
共132条页码: 2/14页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分